Tuesday, January 14, 2014 2:15:33 PM
New technology in cardiovascular LDL-P is the breakthrough technology that all labs will be using in the future. Doctors are beginning to be educated about the how the old LDL-C test is going to be obsolete. Medical technology advances are what make markets move.
Quest Diagnosics needs this technology. DGX 92.00 PPS
LPDX already has 51,000,000 revenues and 50,000,000 cash. Only trading in a float of 10,000,000.
As the restructuring of research and development costs decline the contract/sales for this technology will grow internationally.
Recent news regarding Scripps out of California is just the beginning.
ENJOY THE RIDE!!!!!!! The volume will through this crazy above 100 and vaporize the float with a real company new technology already making millions in a niche market...
SMILING @ 100+
http://www.liposcience.com/about-liposcience/our-technology
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • SBC • Nov 7, 2024 7:00 AM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM